期刊文献+

重组人干扰素α2a凝胶对单纯疱疹病毒感染的疗效 被引量:4

Curative Effect of Recombinant Human Interferon α2a Gel on Herpes Simplex Virus Infection in Animals
下载PDF
导出
摘要 目的研究重组人干扰素α2a(rhIFNα2a)凝胶对动物体内单纯疱疹病毒(HSV)感染的疗效。方法建立HSV-1型豚鼠皮肤感染模型和HSV-2型小鼠阴道炎模型,考察rhIFNα2a凝胶抗HSV作用。将模型豚鼠与小鼠各自分为3个试验组,分别用3×105、2×105和1×105IU/g的rhIFNα2a凝胶治疗,并设平行对照(阿昔洛韦)与空白对照(未治疗)组。评价各组的疗效。结果与空白对照组比较,rhIFNα2a凝胶2×105和3×105IU/g剂量组可明显减少豚鼠皮肤组织中病毒含量,降低小鼠的死亡率,延长生存期。rhIFNα2a凝胶与阿昔洛韦的疗效差异无显著意义。结论rhIFNα2a凝胶具有抑制HSV-1致皮肤病变作用,可缩短病程,对HSV-2所致小鼠阴道炎有较好疗效。 Objective To study the curative effect of recombinant human interferon α2a(rhIFNα2a) gel on in vivo infection with herpes simplex virus(HSV) in animals. Methods The guinea pig model of skin infection with HSV-1 and the mouse model of vaginitis caused by HSV-2 infection were established. Divide the model guinea pigs and mice into three test,one parallel control and one blank control groups separately. Treat the animals in the three test groups with rhIFNα2a gel at dosages of 3 × 10^5,2 × 10^5 and 1 × 10^5 IU/g respectively,while those in parallel control groups with acyclovir. However,the animals in blank control groups were untreated. Evaluate the curative effect of each group. Results The rhIFNα2a gel at dosages of 2 × 10^5 and 3 × 10^5 IU/g decreased the HSV-1 content in skin tissue of guinea pigs as well as the mortality rate of mice, and prolonged the survival period of mice significantly. The curative effect of rhIFNα2a gel showed no significant difference with that of acyclovir. Conclusion rhlFNα2a gel inhibited the pathological change on skin caused by HSV-1 and shortened the course of disease. It showed good curative effect on vaginitis caused by HSV- 2 in mice.
出处 《中国生物制品学杂志》 CAS CSCD 2006年第6期607-609,共3页 Chinese Journal of Biologicals
关键词 干扰素凝胶 单纯疱疹病毒 疗效 动物模型 Interferon gel Herpes simplex virus Curative effect Animal model
  • 相关文献

参考文献2

二级参考文献10

  • 1张玲玲,孟祥伟,迟宝荣.干扰素的基础研究与临床应用[J].中国全科医学,2004,7(22):1715-1716. 被引量:19
  • 2叶兴东,佟菊贞,白桦,李欢.男性生殖器疱疹患者外周血T淋巴细胞亚群分析[J].中国皮肤性病学杂志,1997,11(3):146-147. 被引量:12
  • 3Syed TA, Cheema KM, Kahlon BM, et al. Human leukocyte interferon - alpha in cream for the treatment of genital herpes in Asian males: A placebo - controlled, double -blind study[J ]. Dermatology, 1995,191(1) : 32 - 35.
  • 4Zolin VV, Agafonova OA, Kolokol'tsov AA, et al. Study of the antiviral activity, pharmacokinetics and toxic properties of liposomal form of human alpha - 2b interferon administered topically [ J ]. Vestn Ross Akad Med Nauk,2001,5:27 - 31.
  • 5Shupack J, Stiller M, Davis I, et al. Topical alpha - interferon ointment with dimethyl sulfoxide in the treatment of recurrent genital herpes simplex [J ]. Dermatology 1992,184(1) :40 - 44.
  • 6Sacks SL, Varner TL, Davies KS, et al. Randomized,double - blind, placebo - controlled, patient - initiated study of topical high - and low - dose interferon - alpha with nonoxynol- 9 in the treatment of recurrent genital herpes[J ]. J Infect Dis , 1990,161(4) :692 - 698.
  • 7孙静 何莉 李晏.复方干扰素滴鼻液制备及临床应用[J].药学实践杂志,1995,13(3):170-170.
  • 8Bumelir VA,Janulailis EA,Mainricas M,et al.Stability IFN formulation Lith LT,1996,3987(C1.C12N15/20):25.
  • 9王玉琼.干扰素滴鼻剂治疗小儿急性呼吸道感染疗效观察[J].广东医学,1998,19:126-127.
  • 10Yamauchi H,Tatefuji T, Ikeda M,et al. Prolonged stability of nIFNα lozenges using anhydrous as an excipent. J Pharm Sci Tech, 1995,55: 75.

共引文献12

同被引文献32

  • 1罗红权,杜晓红,刘春岚,刘北忠.单纯疱疹病毒的感染对孕妇及胎儿的影响[J].四川医学,2005,26(3):302-303. 被引量:8
  • 2卢长安,龚翠红,郭伟,富杭育.润喉宁抗病毒作用的研究[J].中成药,1994,16(6):31-33. 被引量:14
  • 3李芳兰.单纯疱疹病毒感染80例治疗体会[J].华中医学杂志,2006,30(5):412-412. 被引量:1
  • 4黄雁翔(综述),陈新月(审校),李卓(审校).干扰素诱导抗病毒蛋白的基因多态性与抗病毒疗效的关系[J].国际病毒学杂志,2007,14(1):1-4. 被引量:6
  • 5Bekisz J, Schmeisser H, Hernandez J, et al. Human interferons alpha, beta and omega [J]. Growth Factors, 2004, 22 (4): 243- 251.
  • 6Walsh G. Biopharmaceutical benchmarks 2006 [J]. Nat Biotechnol, 2006, 24 (7): 769-776.
  • 7Prtimmer O, Seyfarth C, Scherbaum WA, et al. Interferonalpha antibodies in autoimmune diseases [J]. J Interferon Res, 1989, 9 (Suppl 1 ) : $67-$74.
  • 8国家药典委员会.中华人民共和国药典三部[M].1版.北京:化学工业出版社,2005:附录55.
  • 9Wurm FM, Petropoulos CJ. Plasmid integration, amplification and cytogenetics in CHO cells: questions and comments [J]. Biologicals, 1994, 22 (2): 95-102.
  • 10Ank N, West H, Bartholdy C, et al. Lambda interferon (IFN- lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo [J]. J Virol, 2006, 80 (9): 4501-4509.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部